Mortality, hepatic decompensation, and cardiovascular outcomes in lean vs. non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis: A Veterans Affairs cohort study

Abstract: Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has a global prevalence of 25%. Studies on incident liver and cardiovascular …